Athersys Inc Sustainability Reports
Athersys, Inc. is a clinical-stage biotechnology company that develops therapies in the field of regenerative medicine. Its primary focus is on developing its proprietary MultiStem cell therapy platform for neurological, inflammatory, immune, and critical care conditions.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 529900SJN2POLMMUAI78
FIGI: BBG001SS0VB4
14 reports from 2007 to 2022
